Atara Biotherapeutics (ATRA) Other Working Capital Changes (2013 - 2026)

Atara Biotherapeutics' Other Working Capital Changes history runs 7 years deep, the most recent figure standing at -$109000.0 for Q2 2025.

• Quarterly Other Working Capital Changes changed N/A year-over-year to -$109000.0 in Q2 2025, while the trailing twelve-month figure through Mar 2026 was -$109000.0 (up 69.03% YoY) and the FY2025 annual result came in at $1000.0, up 100.22% from the prior year.
• Other Working Capital Changes was -$109000.0 for Q2 2025 at Atara Biotherapeutics, down from $110000.0 in the prior quarter.
• Across five years, Other Working Capital Changes topped out at $79.1 million in Q2 2025 and bottomed at -$79.1 million in Q1 2025.
• A 5-year average of -$1.4 million and a median of -$273000.0 in 2024 frame the typical range for Other Working Capital Changes.
• Peak annual rise in Other Working Capital Changes reached 377.27% in 2023, while the deepest fall reached 204.08% in 2023.
• Atara Biotherapeutics' Other Working Capital Changes stood at -$710000.0 in 2021, then surged by 115.49% to $110000.0 in 2022, then plunged by 69.09% to $34000.0 in 2023, then slumped by 1458.82% to -$462000.0 in 2024, then jumped by 76.41% to -$109000.0 in 2025.
• Business Quant data shows ATRA's Other Working Capital Changes at -$109000.0 in Q2 2025, $110000.0 in Q1 2025, and -$462000.0 in Q4 2024.